Report cover image

Global Oral Proteins and Peptides Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 197 Pages
SKU # APRC20361044

Description

Summary

According to APO Research, The global Oral Proteins and Peptides market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Proteins and Peptides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oral Proteins and Peptides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Oral Proteins and Peptides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Oral Proteins and Peptides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Oral Proteins and Peptides include Novartis, Synergy Pharmaceuticals (Salix), Novo Nordisk, Ironwood & Allergan and Chiasma (Amryt Pharma), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Proteins and Peptides, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Oral Proteins and Peptides, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Proteins and Peptides, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Proteins and Peptides sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oral Proteins and Peptides market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oral Proteins and Peptides sales, projected growth trends, production technology, application and end-user industry.

Oral Proteins and Peptides Segment by Company

Novartis
Synergy Pharmaceuticals (Salix)
Novo Nordisk
Ironwood & Allergan
Chiasma (Amryt Pharma)
Oral Proteins and Peptides Segment by Type

Octreotide
Cyclosporine
Linaclotide
Plecanatide
Insulin
Oral Proteins and Peptides Segment by Application

Gastric & Digestive Disorders
Diabetes
Hormonal Disorders
Bone Diseases
Oral Proteins and Peptides Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Proteins and Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Proteins and Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Proteins and Peptides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Oral Proteins and Peptides in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Oral Proteins and Peptides manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Proteins and Peptides sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Oral Proteins and Peptides Market by Type
1.2.1 Global Oral Proteins and Peptides Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Octreotide
1.2.3 Cyclosporine
1.2.4 Linaclotide
1.2.5 Plecanatide
1.2.6 Insulin
1.3 Oral Proteins and Peptides Market by Application
1.3.1 Global Oral Proteins and Peptides Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Gastric & Digestive Disorders
1.3.3 Diabetes
1.3.4 Hormonal Disorders
1.3.5 Bone Diseases
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Oral Proteins and Peptides Market Dynamics
2.1 Oral Proteins and Peptides Industry Trends
2.2 Oral Proteins and Peptides Industry Drivers
2.3 Oral Proteins and Peptides Industry Opportunities and Challenges
2.4 Oral Proteins and Peptides Industry Restraints
3 Global Market Growth Prospects
3.1 Global Oral Proteins and Peptides Revenue Estimates and Forecasts (2020-2031)
3.2 Global Oral Proteins and Peptides Revenue by Region
3.2.1 Global Oral Proteins and Peptides Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Oral Proteins and Peptides Revenue by Region (2020-2025)
3.2.3 Global Oral Proteins and Peptides Revenue by Region (2026-2031)
3.2.4 Global Oral Proteins and Peptides Revenue Market Share by Region (2020-2031)
3.3 Global Oral Proteins and Peptides Sales Estimates and Forecasts 2020-2031
3.4 Global Oral Proteins and Peptides Sales by Region
3.4.1 Global Oral Proteins and Peptides Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Oral Proteins and Peptides Sales by Region (2020-2025)
3.4.3 Global Oral Proteins and Peptides Sales by Region (2026-2031)
3.4.4 Global Oral Proteins and Peptides Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Oral Proteins and Peptides Revenue by Manufacturers
4.1.1 Global Oral Proteins and Peptides Revenue by Manufacturers (2020-2025)
4.1.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Oral Proteins and Peptides Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Oral Proteins and Peptides Sales by Manufacturers
4.2.1 Global Oral Proteins and Peptides Sales by Manufacturers (2020-2025)
4.2.2 Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Oral Proteins and Peptides Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Oral Proteins and Peptides Sales Price by Manufacturers (2020-2025)
4.4 Global Oral Proteins and Peptides Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Oral Proteins and Peptides Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Oral Proteins and Peptides Manufacturers, Product Type & Application
4.7 Global Oral Proteins and Peptides Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Oral Proteins and Peptides Market CR5 and HHI
4.8.2 2024 Oral Proteins and Peptides Tier 1, Tier 2, and Tier 3
5 Oral Proteins and Peptides Market by Type
5.1 Global Oral Proteins and Peptides Revenue by Type
5.1.1 Global Oral Proteins and Peptides Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Oral Proteins and Peptides Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Oral Proteins and Peptides Revenue Market Share by Type (2020-2031)
5.2 Global Oral Proteins and Peptides Sales by Type
5.2.1 Global Oral Proteins and Peptides Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Oral Proteins and Peptides Sales by Type (2020-2031) & (Kg)
5.2.3 Global Oral Proteins and Peptides Sales Market Share by Type (2020-2031)
5.3 Global Oral Proteins and Peptides Price by Type
6 Oral Proteins and Peptides Market by Application
6.1 Global Oral Proteins and Peptides Revenue by Application
6.1.1 Global Oral Proteins and Peptides Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Oral Proteins and Peptides Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Oral Proteins and Peptides Revenue Market Share by Application (2020-2031)
6.2 Global Oral Proteins and Peptides Sales by Application
6.2.1 Global Oral Proteins and Peptides Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Oral Proteins and Peptides Sales by Application (2020-2031) & (Kg)
6.2.3 Global Oral Proteins and Peptides Sales Market Share by Application (2020-2031)
6.3 Global Oral Proteins and Peptides Price by Application
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Comapny Information
7.1.2 Novartis Business Overview
7.1.3 Novartis Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Novartis Oral Proteins and Peptides Product Portfolio
7.1.5 Novartis Recent Developments
7.2 Synergy Pharmaceuticals (Salix)
7.2.1 Synergy Pharmaceuticals (Salix) Comapny Information
7.2.2 Synergy Pharmaceuticals (Salix) Business Overview
7.2.3 Synergy Pharmaceuticals (Salix) Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Synergy Pharmaceuticals (Salix) Oral Proteins and Peptides Product Portfolio
7.2.5 Synergy Pharmaceuticals (Salix) Recent Developments
7.3 Novo Nordisk
7.3.1 Novo Nordisk Comapny Information
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio
7.3.5 Novo Nordisk Recent Developments
7.4 Ironwood & Allergan
7.4.1 Ironwood & Allergan Comapny Information
7.4.2 Ironwood & Allergan Business Overview
7.4.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio
7.4.5 Ironwood & Allergan Recent Developments
7.5 Chiasma (Amryt Pharma)
7.5.1 Chiasma (Amryt Pharma) Comapny Information
7.5.2 Chiasma (Amryt Pharma) Business Overview
7.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio
7.5.5 Chiasma (Amryt Pharma) Recent Developments
8 North America
8.1 North America Oral Proteins and Peptides Market Size by Type
8.1.1 North America Oral Proteins and Peptides Revenue by Type (2020-2031)
8.1.2 North America Oral Proteins and Peptides Sales by Type (2020-2031)
8.1.3 North America Oral Proteins and Peptides Price by Type (2020-2031)
8.2 North America Oral Proteins and Peptides Market Size by Application
8.2.1 North America Oral Proteins and Peptides Revenue by Application (2020-2031)
8.2.2 North America Oral Proteins and Peptides Sales by Application (2020-2031)
8.2.3 North America Oral Proteins and Peptides Price by Application (2020-2031)
8.3 North America Oral Proteins and Peptides Market Size by Country
8.3.1 North America Oral Proteins and Peptides Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Oral Proteins and Peptides Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Oral Proteins and Peptides Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Oral Proteins and Peptides Market Size by Type
9.1.1 Europe Oral Proteins and Peptides Revenue by Type (2020-2031)
9.1.2 Europe Oral Proteins and Peptides Sales by Type (2020-2031)
9.1.3 Europe Oral Proteins and Peptides Price by Type (2020-2031)
9.2 Europe Oral Proteins and Peptides Market Size by Application
9.2.1 Europe Oral Proteins and Peptides Revenue by Application (2020-2031)
9.2.2 Europe Oral Proteins and Peptides Sales by Application (2020-2031)
9.2.3 Europe Oral Proteins and Peptides Price by Application (2020-2031)
9.3 Europe Oral Proteins and Peptides Market Size by Country
9.3.1 Europe Oral Proteins and Peptides Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Oral Proteins and Peptides Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Oral Proteins and Peptides Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
9.3.9 Nordic Countries
10 China
10.1 China Oral Proteins and Peptides Market Size by Type
10.1.1 China Oral Proteins and Peptides Revenue by Type (2020-2031)
10.1.2 China Oral Proteins and Peptides Sales by Type (2020-2031)
10.1.3 China Oral Proteins and Peptides Price by Type (2020-2031)
10.2 China Oral Proteins and Peptides Market Size by Application
10.2.1 China Oral Proteins and Peptides Revenue by Application (2020-2031)
10.2.2 China Oral Proteins and Peptides Sales by Application (2020-2031)
10.2.3 China Oral Proteins and Peptides Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Oral Proteins and Peptides Market Size by Type
11.1.1 Asia Oral Proteins and Peptides Revenue by Type (2020-2031)
11.1.2 Asia Oral Proteins and Peptides Sales by Type (2020-2031)
11.1.3 Asia Oral Proteins and Peptides Price by Type (2020-2031)
11.2 Asia Oral Proteins and Peptides Market Size by Application
11.2.1 Asia Oral Proteins and Peptides Revenue by Application (2020-2031)
11.2.2 Asia Oral Proteins and Peptides Sales by Application (2020-2031)
11.2.3 Asia Oral Proteins and Peptides Price by Application (2020-2031)
11.3 Asia Oral Proteins and Peptides Market Size by Country
11.3.1 Asia Oral Proteins and Peptides Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Oral Proteins and Peptides Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Oral Proteins and Peptides Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Oral Proteins and Peptides Market Size by Type
12.1.1 SAMEA Oral Proteins and Peptides Revenue by Type (2020-2031)
12.1.2 SAMEA Oral Proteins and Peptides Sales by Type (2020-2031)
12.1.3 SAMEA Oral Proteins and Peptides Price by Type (2020-2031)
12.2 SAMEA Oral Proteins and Peptides Market Size by Application
12.2.1 SAMEA Oral Proteins and Peptides Revenue by Application (2020-2031)
12.2.2 SAMEA Oral Proteins and Peptides Sales by Application (2020-2031)
12.2.3 SAMEA Oral Proteins and Peptides Price by Application (2020-2031)
12.3 SAMEA Oral Proteins and Peptides Market Size by Country
12.3.1 SAMEA Oral Proteins and Peptides Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Oral Proteins and Peptides Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Oral Proteins and Peptides Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Oral Proteins and Peptides Value Chain Analysis
13.1.1 Oral Proteins and Peptides Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Oral Proteins and Peptides Production Mode & Process
13.2 Oral Proteins and Peptides Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Oral Proteins and Peptides Distributors
13.2.3 Oral Proteins and Peptides Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.